Tobacco use and cataracts in patients with schizophrenia.
Foulds
Jonathan
J
Williams
Jill
J
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002386:Cataract / Q000139:chemically induced / Q000175:diagnosis / Q000209:etiology*; D032921:Consensus; D003987:Dibenzothiazepines / Q000009:adverse effects / Q000627:therapeutic use; D004348:Drug Labeling; D006801:Humans; D000069348:Quetiapine Fumarate; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality*; D012565:Schizophrenic Psychology; D012907:Smoking / Q000009:adverse effects* / Q000523:psychology; D000074606:Smoking Prevention; D014029:Tobacco Use Disorder / Q000150:complications / Q000517:prevention & control; D014787:Vision Tests / Q000706:statistics & numerical data*
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate